Wednesday, January 31, 2024

January 31, 2024 at 01:45PM STRATAGRAFT

For the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Al7YGer

January 31, 2024 at 07:07PM About CBER

The Center for Biologics Evaluation and Research (CBER) is one Center within the Food and Drug Administration, an Agency within the United States Government's Department of Health and Human Services

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/OGoiVIY

Tuesday, January 30, 2024

January 30, 2024 at 11:19PM FDA Roundup: January 30, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/9d2m0h7

January 30, 2024 at 04:58PM CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19

CDER Scientific Reviews Supporting EUA for Therapeutic Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/leny97L

January 30, 2024 at 02:16PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/pQgJNO5

January 30, 2024 at 02:08PM Charter of the Vaccines and Related Biological Products Advisory Committee

This is the Charter of the Vaccines and Related Biological Products Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/i78JXNo

Monday, January 29, 2024

January 29, 2024 at 11:57PM GAMMAGARD LIQUID

Product approval information is indicated for:
• Replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older.
• Maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KoPGLMx

January 29, 2024 at 02:42PM Cellular & Gene Therapy Guidances

This page contains a listing of cellular and gene therapy guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HK2XAY6

Friday, January 26, 2024

January 26, 2024 at 06:02PM Section 8100: Communication

This is the CBER SOPP Section 8100: Communication main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/SqtmB5G

January 26, 2024 at 02:00PM Conducting Remote Regulatory Assessments Questions and Answers

Conducting Remote Regulatory Assessments Questions and Answers Draft Guidance for Industry

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/fGhdYRU

January 26, 2024 at 12:38PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/gVLpSG6

Thursday, January 25, 2024

January 25, 2024 at 09:45PM ADYNOVATE

Product approval information is indicated for children and adults with hemophilia A (congenital factor VIII deficiency) for: (1) On-demand treatment and control of bleeding episodes; (2) Perioperative management; (3) Routine prophylaxis to reduce the frequency of bleeding episodes.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/eKSxODL

January 25, 2024 at 08:53PM Vaccines and Related Biological Products Advisory Committee October 5, 2023 Meeting Announcement - 10/05/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) October 5, 2023 announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/MIT15Ha

Wednesday, January 24, 2024

January 24, 2024 at 04:47PM Cellular, Tissue, and Gene Therapies Advisory Committee October 31, 2023 Meeting Announcement - 10/31/2023

This is the CBER Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) October 31, 2023 meeting announcement and materials main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qzTgJad

Tuesday, January 23, 2024

January 23, 2024 at 10:13PM FDA Roundup: January 23, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Y7G6Bpj

Monday, January 22, 2024

January 22, 2024 at 09:01PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vaCeDSx

Friday, January 19, 2024

January 19, 2024 at 08:13PM Biomarker-driven Drug Development for Allergic Diseases and Asthma; Public Workshop - 02/22/2024

This public workshop is intended to be a forum for the exchange of information and perspectives among regulators and academic investigators on the use of biomarkers to monitor, predict efficacy, and evaluate responses to novel therapeutics for allergic diseases.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/i7nItNB

January 18, 2024 at 09:49PM Biologics Electronic Reading Room (eFOIA)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/oArYyM0

Wednesday, January 17, 2024

January 18, 2024 at 12:29AM Industry Frequently Asked Questions

Frequently asked questions and the associated answers sorted by topic area

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/sOVAyw5

January 17, 2024 at 07:25PM Medical Device User Fee Small Business Qualification and Certification

This guidance describes the process for how a business may request qualification and certification as a small business.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Jb6QFuT

January 17, 2024 at 02:03PM Licensed Biological Products with Supporting Documents

Licensed biological products with supporting documents is arranged alphabetically by the proper name of the product(s). Information is provided for original product approvals, new indications, and the current package insert.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mvYbUV1

Tuesday, January 16, 2024

January 16, 2024 at 09:27PM FDA Roundup: January 16, 2024

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WHQCB3m

January 16, 2024 at 05:45PM HYQVIA

Indicated for the treatment of Primary Immunodeficiency (PI) in adults.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/x54gdoy

January 16, 2024 at 01:40PM BIMO/Team Biologics/Internet Surveillance/Other

This is the main page for the CBER BIMO/Team Biologics/Internet Surveillance/Other.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4MDV721

January 12, 2024 at 02:55PM Vaccines

CBER regulates vaccine products. Vaccine information includes a listing of vaccines approved for marketing, questions about vaccines, vaccine safety and availability, and vaccine-related guidance documents, notices, and rules.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/e2A5T1k

January 12, 2024 at 02:51PM Questions about Vaccines

Information on general and specific vaccines

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WcqX3RO

Thursday, January 11, 2024

January 11, 2024 at 02:16PM Kimera Labs, Inc. - 649343 - 09/01/2023

Investigational Device Exemptions (IDE)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Ad8bPVH

Wednesday, January 10, 2024

January 10, 2024 at 04:46PM IXCHIQ

For the prevention of disease caused by chikungunya virus (CHIKV) in
individuals 18 years of age and older who are at high risk of exposure to CHIKV.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QaI5M6k

January 09, 2024 at 09:36PM Section 8400: Marketing Applications

This is the SOPP Section 8400: Marketing Applications main page.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/YCW7icM

January 09, 2024 at 08:59PM Staff Fellow/Visiting Associate – Pharmacology/Toxicology Reviewer

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP), Office of Pharmacology/Toxicology (OPT) is recruiting to fill multiple Staff Fellow/Visiting Associate positions to serve as Pharmacology/Toxicology Reviewers.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4IuSt5i

January 09, 2024 at 07:04PM FDA Approves Many New Drugs in 2023 that Will Benefit Patients and Consumers

FDA’s Center for Drug Evaluation and Research (CDER) approved a wide range of therapies in 2023 that will help patients and consumers live better and possibly longer lives.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/f7uLZ2S

January 09, 2024 at 03:20PM MiMedx Group, Inc. - 662942 - 12/20/2023

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2YDyaUz

Friday, January 5, 2024

January 05, 2024 at 06:26PM RECOTHROM

Product approval information is indicated for An aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical in adults and pedi

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0I6TnoU

January 05, 2024 at 05:44PM 2023 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

This is the main page for the CBER 2023 Meeting Materials, Vaccines and Related Biological Products Advisory Committee (VRBPAC).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4WzsEbx

Thursday, January 4, 2024

January 05, 2024 at 12:00AM Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement - 03/03/2022

This is the CBER Vaccines and Related Biological Products Advisory Committee March 3, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/BsMRX20

January 04, 2024 at 11:18PM POSTPONED- Vaccines and Related Biological Products Advisory Committee February 15, 2022 Meeting Announcement - 02/15/2022

This the CBER Vaccines and Related Biological Products Advisory Committee February 15, 2022 Meeting Announcement

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HBi3sKZ

January 04, 2024 at 08:36PM CBER Vaccine ICSR Implementation

The CBER ICSR Implementation webpage was created to provide current information about CBER’s progress toward the adoption and implementation of the ISO/HL7 Individual Case Safety Report (ICSR) standard and the ICH E2B(R3) revised content specification to support electronic reporting to the Vaccine A

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/LjcnP7p

January 04, 2024 at 07:46PM Getting Started with ICSR Submission to FDA’s electronic Vaccine Adverse Event Reporting System (eVAERS)

Follow the steps below for submitting ICSRs to the FDA's electronic Vaccine Adverse Event Reporting System (eVAERS).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZiYktlD

Wednesday, January 3, 2024

January 03, 2024 at 09:46PM Vaccines and Related Biological Products Advisory Committee June 7, 2022 Meeting Announcement - 06/07/2022

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee June 7, 2022 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/w8EY6IM

January 03, 2024 at 04:07PM CASGEVY

CASGEVY indicated for the treatment of sickle cell disease (SCD) in patients 12 years and older with recurrent vaso occlusive crises (VOCs).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XdJDS3v

Tuesday, January 2, 2024

December 29, 2023 at 07:49PM Roster of the Vaccines and Related Biological Products Advisory Committee

This is the Roster of the Vaccines and Related Biological Products Advisory Committee

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/XRj8CWy

January 02, 2024 at 06:40PM Vaccines and Related Biological Products Advisory Committee June 28, 2022 Meeting Announcement - 06/28/2022

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee June 28, 2022 Meeting Announcement.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4BfGZHy